Lens On The Scientific Market
Key findings from our industry experts.
Key findings from our industry experts.
NAMs Shift from Policy to Practice: What Life Science R&D Suppliers Need to Know in 2026
March 11, 2026 3:51 pm
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.

Scientists as Consumers
In our last post we described the market’s sellers – the biotech tools companies. But in order for there to be a market there has to be a buyer—in this case, life scientists working in pharmaceutical, biotechnology, university, and government labs. (As an aside, I hate it when people use the word “space” when they […]
The Market’s Sellers Through The Looking Glass
The news continues to be filled with stories about failed clinical trials, slashed R&D budgets and the social controversies surrounding cloning, gene therapy and stem cells. This makes it easy to forget that the biotechnology industry continues to be full of promise-an industry whose contributions to science have been compared to the impact of the […]
Welcome to The Looking Glass
Welcome to our blog. My fellow bloggers and I occupy a fairly unique position in the life science industry…here at BioInformatics, LLC (https://bioinfoinc.com) we help companies make better business decisions. Simply put, we work for companies that sell products and services to scientists. In our 13 years in business we’ve worked for every leading life […]